J7179 HCPCS Level II code: Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
J7179 is the HCPCS code for “Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
Short description: Vonvendi inj 1 iu vwf:rco
HCPCS · United States
Notes for J7179
As CMS prints them, with any note J7179 takes from the headings above it.
Note
- CMS processing note 0211: PUB 100-4, CH 17, SEC 80.4.
Medicare details
The indicators CMS publishes with J7179 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2017
Where J7179 sits
- 1J codesDrugs administered other than orally
- 2Active code J7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7179 mean?
J7179 is the HCPCS code for “Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7179?
CMS lists J7179’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7179
All J codesJ7173Injection, concizumab-mtci, 0.5 mgJ7174Injection, fitusiran, 0.04 mgJ7175Injection, factor x, (human), 1 i.u.J7176Injection, human fibrinogen - chmt (fesilty), 1 mgJ7177Injection, human fibrinogen concentrate (fibryga), 1 mgJ7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mgJ7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.J7181Injection, factor xiii a-subunit, (recombinant), per iuJ7182Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iuJ7183Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rcoJ7185Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.J7186Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.